Chief Scientific Officer & COO
Wed, Jun 5, 2024
Jun 5
114 shares @ $45.00
Decreased holdings by 0.00%
31st largest trade (out of 33)
Planned (10b5-1)Positive 90D History
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
75% win rate · +24.1% median edge vs SPY (16 trades, 90-day · small sample)
Price 49% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
ARCTArcturus Therapeutics Holdings Inc.
HealthcareBiotechnology
1D0.00%
1W+30.79%
1M+71.62%
3M+46.23%
6M—
1Y—